Hall Capital Management Co. Inc. Purchases 120 Shares of The Clorox Company $CLX

Hall Capital Management Co. Inc. boosted its position in The Clorox Company (NYSE:CLX) by 4.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,851 shares of the company’s stock after acquiring an additional 120 shares during the period. Hall Capital Management Co. Inc.’s holdings in Clorox were worth $342,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CLX. Park Avenue Securities LLC bought a new position in Clorox in the first quarter worth approximately $258,000. Wedge Capital Management L L P NC boosted its holdings in Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock worth $4,198,000 after acquiring an additional 7,159 shares in the last quarter. Courier Capital LLC raised its stake in shares of Clorox by 11.6% in the first quarter. Courier Capital LLC now owns 2,785 shares of the company’s stock worth $410,000 after purchasing an additional 290 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Clorox by 25.4% in the first quarter. Farther Finance Advisors LLC now owns 5,872 shares of the company’s stock worth $869,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Pallas Capital Advisors LLC purchased a new stake in shares of Clorox in the first quarter worth approximately $647,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $120.49 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market capitalization of $14.74 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 0.97 and a beta of 0.52. The stock has a 50 day moving average of $122.51 and a 200 day moving average of $129.17. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue was up 4.5% on a year-over-year basis. During the same period last year, the business posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.57% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Citigroup reissued a “neutral” rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Morgan Stanley lowered their price objective on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Barclays lowered their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. TD Cowen lowered their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Finally, JPMorgan Chase & Co. increased their price objective on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a research note on Monday, September 8th. One investment analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus price target of $134.08.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.